Discover
SGMT
Sagimet Biosciences Inc.
8.93
2 x 5.84
2 x 10.26
bid
ask
+
0.01
0.11%
2 @ 04:01 PM
8.93 +0.00 (0.00%)
| Ytd | 50.84% | |
| 1y | 3.60% |
8.82
day range
9.05
4.55
52 week range
11.17
| Open | 8.84 | Prev Close | 8.92 | Low | 8.82 | High | 9.05 | Mkt Cap | 633.21M |
| Vol | 763.53K | Avg Vol | 1.24M | EPS | -1.27 | P/E | N/A | Forward P/E | -1.40 |
| Beta | 3.46 | Short Ratio | 1.37 | Inst. Own | 66.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 9.88 | 200-d Avg | 7.23 | 1yr Est | 29.14 |
| Income Statement | |||
| Operating Expenses | 15.82M | ||
| Research and Development Expense | 11.54M | ||
| Selling, General and Administrative Expense | 4.28M | ||
| Operating Income | -15.82M | ||
| Net Income | -13.95M | ||
| Net Income Common Stock | -13.95M | ||
| Net Income Common Stock (USD) | -13.95M | ||
| Consolidated Income | -13.95M | ||
| Earnings per Basic Share | -0.26 | ||
| Earnings per Basic Share (USD) | -0.26 | ||
| Earnings per Diluted Share | -0.26 | ||
| Earning Before Interest & Taxes (EBIT) | -13.95M | ||
| Earning Before Interest & Taxes (USD) | -13.95M | ||
| Weighted Average Shares | 53.11M | ||
| Weighted Average Shares Diluted | 53.11M | ||
| Balance Sheet | |||
| Cash and Equivalents | 165.90M | ||
| Cash and Equivalents (USD) | 165.90M | ||
| Investments | 91.67M | ||
| Investments Current | 74.23M | ||
| Investments Non-Current | 17.44M | ||
| Current Assets | 243.99M | ||
| Property, Plant & Equipment Net | 1.95M | ||
| Total Assets | 263.43M | ||
| Debt Current | 84.00K | ||
| Total Debt | 1.94M | ||
| Current Liabilities | 5.42M | ||
| Debt Non-Current | 1.86M | ||
| Total Liabilities | 7.28M | ||
| Accumulated Retained Earnings (Deficit) | -370.95M | ||
| Accumulated Other Comprehensive Income | -77.00K | ||
| Shareholders Equity | 256.15M | ||
| Shareholders Equity (USD) | 256.15M | ||
| Assets Non-Current | 19.44M | ||
| Total Debt (USD) | 1.94M | ||
| Liabilities Non-Current | 1.86M | ||
| Trade and Non-Trade Payables | 1.13M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 39.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 129.27M | ||
| Net Cash Flow from Investing | -24.02M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -24.02M | ||
| Net Cash Flow from Operations | -11.10M | ||
| Share Based Compensation | 3.69M | ||